Adam Ian Kaplin MD PhD
Neuropsychiatry
Principle Psychiatric Consultant to JHM MS Center, Depts of Psychiatry & Neurology, Assistant Professor of Neurology, Johns Hopkins University School of Medicine
Join to View Full Profile
600 N. Wolfe StreetOsler 320Baltimore, MD 21287
Phone+1 410-929-5544
Fax+1 410-213-3167
Dr. Kaplin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Psychiatry, 1997 - 2000- Johns Hopkins UniversityInternship, Internal Medicine, 1996 - 1997
- Johns Hopkins University School of MedicineClass of 1996
Certifications & Licensure
MD State Medical License 1998 - 2026
American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsNational Network of Depression Centers position statement: Insurance coverage for intravenous ketamine in treatment-resistant major depressive disorder.Mark J Niciu, Robert C Meisner, Brent R Carr, Ali A Farooqui, David Feifel
Journal of Affective Disorders. 2024-02-01 - A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Do...Jenna Brager, Chris Chapman, Leonard Dunn, Adam Kaplin
Drug Research. 2023-02-01 - 101 citationsAddressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care.Anne M. Parker, Emily P. Brigham, Bronwen Connolly, Joanne McPeake, Anna V. Agranovich
The Lancet. Respiratory Medicine. 2021-11-01
Press Mentions
What Top MS Researchers Want You to Know About MS Care and Treatment Right NowMay 25th, 2022- The Never-Ending Battle: New Study Shows Long Covid Can Last at Least 15 MonthsMay 24th, 2022
- Ketamine Therapy Will Go Mainstream in 2022—for Better or WorseDecember 31st, 2021
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/adam-kaplin
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
